These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34388696)

  • 21. Individualized Prediction of Survival Benefit from Postmastectomy Radiotherapy for Patients with Breast Cancer with One to Three Positive Axillary Lymph Nodes.
    Zhang N; Zhang J; Zhang H; Liu Y; Zhao W; Wang L; Chen B; Moran MS; Haffty BG; Yang Q
    Oncologist; 2019 Dec; 24(12):e1286-e1293. PubMed ID: 31315963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-world impact of postmastectomy radiotherapy in T1-2 breast cancer with one to three positive lymph nodes.
    Li FY; Lian CL; Lei J; Wang J; Hua L; He ZY; Wu SG
    Ann Transl Med; 2020 Apr; 8(7):489. PubMed ID: 32395533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes.
    Yin H; Qu Y; Wang X; Ma T; Zhang H; Zhang Y; Li Y; Zhang S; Ma H; Xing E; Liu X; Xu Q
    Oncotarget; 2017 Jul; 8(30):49564-49573. PubMed ID: 28484094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmastectomy radiation therapy for breast cancer patients with one to three positive lymph nodes: a propensity score matching analysis.
    Lin J; Li C; Zhang C; Shi F; Wang H
    Future Oncol; 2017 Jul; 13(16):1395-1404. PubMed ID: 28381104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal Trends in Postmastectomy Radiation Therapy and Breast Reconstruction Associated With Changes in National Comprehensive Cancer Network Guidelines.
    Frasier LL; Holden S; Holden T; Schumacher JR; Leverson G; Anderson B; Greenberg CC; Neuman HB
    JAMA Oncol; 2016 Jan; 2(1):95-101. PubMed ID: 26539936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant Radiation Therapy for T3N0 Breast Cancer Patients Older Than 75 Years After Mastectomy: A SEER Analysis.
    Chen J; Wu X; Christos P; Yan W; Ravi A
    Clin Breast Cancer; 2018 Oct; 18(5):e967-e973. PubMed ID: 29914691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.
    Cassidy RJ; Liu Y; Kahn ST; Jegadeesh NK; Liu X; Subhedar PD; Arciero CA; Gillespie TW; Torres MA
    Cancer; 2017 Aug; 123(15):2829-2839. PubMed ID: 28387923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy.
    Tendulkar RD; Rehman S; Shukla ME; Reddy CA; Moore H; Budd GT; Dietz J; Crowe JP; Macklis R
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e577-81. PubMed ID: 22560546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer.
    Zhang L; Tang R; Deng JP; Zhang WW; Lin HX; Wu SG; He ZY
    BMC Cancer; 2020 Nov; 20(1):1146. PubMed ID: 33238939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postmastectomy Radiation in Breast Cancer Patients With Pathologically Positive Lymph Nodes After Neoadjuvant Chemotherapy: Usage Rates and Survival Trends.
    Ohri N; Moshier E; Ho A; Green S; Rhome R; Mazumdar M; Powell S; Tsai CJ
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):549-559. PubMed ID: 29280449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-Based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418).
    Kim YJ; Park W; Ha B; Park B; Joo J; Kim TH; Park IH; Lee KS; Lee ES; Shin KH; Kim H; Yu JI; Choi DH; Huh SJ; Wee CW; Kim K; Park KR; Kim YB; Ahn SJ; Lee JH; Kim JH; Chun M; Lee HS; Kim JS; Cha J
    Cancer Res Treat; 2017 Oct; 49(4):927-936. PubMed ID: 28052654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postmastectomy radiation therapy in T3 node-negative breast cancer.
    Elmore L; Deshpande A; Daly M; Margenthaler JA
    J Surg Res; 2015 Nov; 199(1):90-6. PubMed ID: 25976852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of different lymph node staging systems in predicting prognosis and determining indications for postmastectomy radiotherapy in patients with T1-T2pN1 breast carcinoma.
    Kustić D; Klarica Gembić T; Grebić D; Petretić Majnarić S; Nekić J
    Strahlenther Onkol; 2020 Nov; 196(11):1044-1054. PubMed ID: 32710122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postmastectomy radiation and survival in older women with breast cancer.
    Smith BD; Haffty BG; Hurria A; Galusha DH; Gross CP
    J Clin Oncol; 2006 Oct; 24(30):4901-7. PubMed ID: 17050874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should all breast cancer patients with four or more positive lymph nodes who underwent modified radical mastectomy be treated with postoperative radiotherapy? A population-based study.
    Wang H; Kong L; Zhang C; Chen D; Zhu H; Yu J
    Oncotarget; 2016 Nov; 7(46):75492-75502. PubMed ID: 27690343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer.
    Goodman CR; Seagle BL; Kocherginsky M; Donnelly ED; Shahabi S; Strauss JB
    Clin Cancer Res; 2018 Aug; 24(16):3878-3887. PubMed ID: 29685878
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of postmastectomy radiotherapy on pT
    Guo XY; Sun GY; Wang HM; Liu M; Zhang YJ; Zhang N; Tang Y; Zhao XR; Jing H; Fang H; Wen G; Guo QS; Wu HF; Wang XH; Ma CY; Li YX; Cheng J; Shi M; Wang SL
    Breast; 2022 Feb; 61():108-117. PubMed ID: 34942430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes.
    Moo TA; McMillan R; Lee M; Stempel M; Patil S; Ho A; El-Tamer M
    Ann Surg Oncol; 2013 Oct; 20(10):3169-74. PubMed ID: 23975289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nomogram predicting survival as a selection criterion for postmastectomy radiotherapy in patients with T1 to T2 breast cancer with 1 to 3 positive lymph nodes.
    Tang Y; Zhang YJ; Zhang N; Shi M; Wen G; Cheng J; Wang HM; Liu M; Wang XH; Guo QS; Wu HF; Ma CY; Jin J; Liu YP; Song YW; Fang H; Ren H; Wang SL; Li YX
    Cancer; 2020 Aug; 126 Suppl 16():3857-3866. PubMed ID: 32710662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-world outcomes of postmastectomy radiotherapy in breast cancer patients with 1-3 positive lymph nodes: a retrospective study.
    Chitapanarux I; Tharavichitkul E; Jakrabhandu S; Klunklin P; Onchan W; Srikawin J; Pukanhaphan N; Traisathit P; Vongtama R
    J Radiat Res; 2014 Jan; 55(1):121-8. PubMed ID: 23788495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.